<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18756" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Caffeine</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Evans</surname>
            <given-names>Justin</given-names>
          </name>
          <aff>Desert Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Richards</surname>
            <given-names>John R.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Battisti</surname>
            <given-names>Amanda S.</given-names>
          </name>
          <aff>Grand Strand Medical Ctr</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Justin Evans declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>John Richards declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amanda Battisti declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18756.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Caffeine is a naturally occurring central nervous system stimulant belonging to the methylxanthine class and is widely recognized as the most utilized psychoactive stimulant worldwide.&#x000a0;Although this drug is most commonly sourced from coffee beans, it can also naturally occur in certain types of tea and cacao beans and&#x000a0;as an additive to soda and energy drinks.&#x000a0;Caffeine consumption primarily alleviates fatigue and drowsiness but has numerous additional therapeutic applications. The US Food and Drug Administration (FDA) has approved caffeine for treating apnea of prematurity. Off-label uses of caffeine include the treatment of migraines&#x000a0;and post-dural puncture headaches, as well as enhancing athletic performance, particularly in endurance sports.</p>
        <p>This activity centers on the mechanism of action, adverse event profile, toxicity, dosing, and monitoring of caffeine, empowering clinicians to identify potential adverse reactions, make informed prescribing decisions, and mitigate risks effectively.&#x000a0;This activity underscores how the interprofessional healthcare team's comprehensive knowledge of caffeine's indicated and off-label uses contributes to enhanced patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify appropriate indications for caffeine therapy in clinical practice, including but not limited to apnea of prematurity, migraines, and post-dural puncture headaches.</p></list-item><list-item><p>Implement evidence-based strategies for dosing caffeine, considering individual patient characteristics and therapeutic goals.</p></list-item><list-item><p>Apply knowledge of caffeine's mechanism of action and pharmacokinetics to make informed prescribing decisions and monitor treatment efficacy.</p></list-item><list-item><p>Collaborate with interprofessional healthcare team members to ensure comprehensive patient care, particularly in populations with unique caffeine-related considerations, such as pregnant women and infants.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18756&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18756">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18756.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Caffeine is a naturally occurring&#x000a0;central nervous system (CNS)&#x000a0;stimulant belonging to the methylxanthine class and is widely recognized as the most utilized psychoactive stimulant worldwide.&#x000a0;Although this drug is most commonly sourced from coffee beans, it can also naturally occur in certain types of tea and cacao beans.&#x000a0;Moreover, the stimulant is also an additive to soda and energy drinks. Caffeine consumption primarily alleviates fatigue and drowsiness but has numerous additional therapeutic applications.</p>
        <p>
<bold>FDA-Approved Indications</bold>
</p>
        <p>The US Food and Drug Administration (FDA) has approved oral caffeine for restoring mental alertness or wakefulness in fatigue or drowsiness.<bold>&#x000a0;</bold>The FDA has also approved intravenous (IV) caffeine for use in the treatment of apnea of prematurity.<xref ref-type="bibr" rid="article-18756.r1">[1]</xref><xref ref-type="bibr" rid="article-18756.r2">[2]</xref><xref ref-type="bibr" rid="article-18756.r3">[3]</xref>&#x000a0;Recommendations&#x000a0;from The Association for Professionals in Infection Control and Epidemiology, the Society for Healthcare Epidemiology, the Infectious Diseases Society of America, the American Hospital Association, and The Joint Commission Consensus endorse the use of caffeine within 72 hours after childbirth to aid extubation for the treatment of apnea of prematurity.<xref ref-type="bibr" rid="article-18756.r4">[4]</xref></p>
        <p>
<bold> Off-Label Uses</bold>
</p>
        <p>IV caffeine is also used for the prevention and treatment of bronchopulmonary dysplasia in premature infants, which often coexists with apnea of prematurity.<xref ref-type="bibr" rid="article-18756.r5">[5]</xref><xref ref-type="bibr" rid="article-18756.r6">[6]</xref>&#x000a0;Off-label uses of caffeine include the treatment of migraines&#x000a0;and post-dural puncture headaches, as well as enhancing athletic performance, particularly in endurance sports.<xref ref-type="bibr" rid="article-18756.r7">[7]</xref><xref ref-type="bibr" rid="article-18756.r8">[8]</xref><xref ref-type="bibr" rid="article-18756.r9">[9]</xref>&#x000a0;Caffeine is associated with decreased all-cause mortality.<xref ref-type="bibr" rid="article-18756.r10">[10]</xref><xref ref-type="bibr" rid="article-18756.r11">[11]</xref>&#x000a0;Moreover, ongoing investigations are exploring its potential efficacy in treating depression and neurocognitive declines, including those observed in Alzheimer and Parkinson diseases.<xref ref-type="bibr" rid="article-18756.r12">[12]</xref><xref ref-type="bibr" rid="article-18756.r13">[13]</xref><xref ref-type="bibr" rid="article-18756.r14">[14]</xref>&#x000a0;</p>
        <p>According to the American Academy of Family Physicians (AAFP), the&#x000a0;combination of acetaminophen, aspirin, and caffeine demonstrates strong evidence of effectiveness in treating acute migraines.<xref ref-type="bibr" rid="article-18756.r15">[15]</xref>&#x000a0;Additionally, acute consumption of caffeine capsules significantly improves muscle strength and endurance, particularly in men. Recent meta-analyses indicate that ingesting caffeine 45 minutes before exercise improves muscle strength and endurance in men.<xref ref-type="bibr" rid="article-18756.r16">[16]</xref></p>
      </sec>
      <sec id="article-18756.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Caffeine's primary mechanism of action involves its effects on adenosine receptors in the brain. Being both fat- and water-soluble component, caffeine easily crosses the blood-brain barrier and antagonizes all 4 adenosine receptor subtypes (A1, A2a, A2b, and A3). The antagonism of the A2a receptor is particularly responsible for caffeine's wakefulness effects.<xref ref-type="bibr" rid="article-18756.r17">[17]</xref><xref ref-type="bibr" rid="article-18756.r18">[18]</xref></p>
        <p>Adenosine receptors are not limited to the CNS but are&#x000a0;present throughout the body. Direct antagonism of receptor A1 in cardiac muscles results in positive inotropic effects. Likewise, adenosine receptor antagonism stimulates the release of catecholamines, contributing to the systemic stimulatory effects of caffeine and further stimulating cardiac inotropy and chronotropy. At the vascular level, caffeine undergoes complex interactions to control vascular tone, including direct antagonism of vascular adenosine receptors to promote vasodilation and stimulate endothelial cells to release nitric oxide, which further relaxes vascular smooth muscle cells.</p>
        <p>This vasodilation&#x000a0;is counteracted by increased sympathetic tone via catecholamine release and positive cardiac inotropic and chronotropic effects, promoting vasoconstriction. Multiple mechanisms of constriction and dilation are at work, resulting in an individualized response dependent on caffeine dose, frequency of use, and comorbidities such as diabetes or hypertension. With infrequent use, caffeine appears to increase systolic blood pressure by approximately 5 to 10 mm Hg. However, little to no acute effect is observed in habitual consumers.<xref ref-type="bibr" rid="article-18756.r19">[19]</xref></p>
        <p>Furthermore, blocking adenosine receptors stimulates respiratory drive by increasing the medullary ventilatory response to carbon dioxide, enhancing central respiratory drive, and improving diaphragm contractility. Caffeine increases renal blood flow, glomerular filtration, and sodium excretion, resulting in diuresis. Additionally, caffeine is a potent stimulator of gastric acid secretion and gastrointestinal motility.<xref ref-type="bibr" rid="article-18756.r18">[18]</xref><xref ref-type="bibr" rid="article-18756.r20">[20]</xref></p>
        <p>
<bold>Pharmacokinetics</bold>
</p>
        <p><bold>Absorption:</bold> Caffeine has nearly 100% oral bioavailability and is the primary route of administration. In preterm neonates, the average time to achieve peak concentration (Tmax) after oral administration varies between 30 minutes and 2 hours.</p>
        <p><bold>Distribution:</bold>&#x000a0;Caffeine is rapidly distributed to the brain. The average volume of caffeine distribution in infants (0.8-0.9 L/kg) is slightly higher than in adults (0.6 L/kg). In adults, approximately 36% of caffeine is bound to plasma proteins.<xref ref-type="bibr" rid="article-18756.r21">[21]</xref></p>
        <p><bold>Metabolism:</bold>&#x000a0;Caffeine is primarily metabolized in the liver via the cytochrome P450 oxidase system, specifically the enzyme CYP1A2. This metabolism results in 1 of 3 dimethylxanthines, including paraxanthine, theobromine, and theophylline, each with unique&#x000a0;effects on the body. These metabolites are then further metabolized and excreted in the urine.<xref ref-type="bibr" rid="article-18756.r19">[19]</xref><xref ref-type="bibr" rid="article-18756.r22">[22]</xref><xref ref-type="bibr" rid="article-18756.r23">[23]</xref></p>
        <p><bold>Excretion:</bold> Although the half-life of caffeine in the average adult is approximately 5 hours, multiple factors can influence the metabolism and duration. In smokers, the half-life is reduced by up to 50% compared to nonsmokers. Conversely, pregnant patients, especially in the final trimester, may experience a prolonged half-life of up to 15 hours. Newborns also have significantly prolonged half-lives&#x02014;up to 8 hours for full-term infants and 100 hours for premature infants&#x02014;due to reduced activity of cytochrome P450 enzymes and immature demethylation pathways. Children older than 9 months have similar half-life eliminations to adults. Additionally, patients with liver disease or those taking cytochrome inhibitors will experience prolonged half-lives due to reduced enzyme activity.<xref ref-type="bibr" rid="article-18756.r24">[24]</xref><xref ref-type="bibr" rid="article-18756.r25">[25]</xref></p>
      </sec>
      <sec id="article-18756.s4" sec-type="Administration">
        <title>Administration</title>
        <p>
<bold>Available Dosage Forms and Strengths</bold>
</p>
        <p>Caffeine is obtainable from various sources, including coffee beans, cacao beans, kola nuts, tea leaves, yerba mate, and the guarana berry. In addition, caffeine is commonly found as an additive in sodas and energy drinks or consumed in powder or tablet form.<xref ref-type="bibr" rid="article-18756.r7">[7]</xref>&#x000a0;Absorption may be slightly delayed when taken with food.&#x000a0;The stimulant&#x000a0;can be administered via the parenteral route, which is a standard method when treating apnea of prematurity in newborns or post-dural puncture headaches. IV formulations&#x000a0;are available in 60 mg/3 mL caffeine citrate vials, providing an equivalent dosage of 10 mg/mL caffeine.</p>
        <p>Alternatively, caffeine can be absorbed rectally, insufflated, or inhaled. However, consumption through insufflation or inhalation is typically considered a form of misuse aimed at achieving a "high." These routes result in much faster absorption, typically within minutes, and bypass the first-pass metabolism. Although this route can lead to a faster onset of action, multiple studies have demonstrated lower bioavailability from inhaling caffeine, approximately 60% to 70%. Consequently, when taken via these routes, the duration of action is shorter.<xref ref-type="bibr" rid="article-18756.r22">[22]</xref><xref ref-type="bibr" rid="article-18756.r26">[26]</xref></p>
        <p>
<bold>Specific Patient Populations</bold>
</p>
        <p><bold>Hepatic impairment:&#x000a0;</bold>Caffeine's product labeling does not specify dosage adjustments for individuals with hepatic impairment. However, individuals with advanced cirrhosis may experience delayed caffeine metabolism, leading to adverse&#x000a0;drug reactions such as insomnia, nervousness, and headaches, even at intake levels that are typically well tolerated by individuals without liver disease. While caffeine may offer modest protective effects against the progression of chronic liver disease, energy drinks containing harmful supplements may contribute to liver injury.<xref ref-type="bibr" rid="article-18756.r27">[27]</xref></p>
        <p><bold>Renal impairment:</bold>&#x000a0;Product labeling does not specify dosage adjustments for renal impairment. Although exposure to caffeine is associated with decreased rates of acute kidney injury during the acute phase in premature neonates, this effect is not observed in term neonates. However, the impact of caffeine exposure on the severity of acute kidney injury, length of hospital stay, morbidity, or mortality remains uncertain. The optimal caffeine dosage for renal protection in neonates has yet to be determined.<xref ref-type="bibr" rid="article-18756.r28">[28]</xref></p>
        <p><bold>Pregnancy considerations:&#x000a0;</bold>Caffeine readily crosses the placenta. The American College of Obstetricians and Gynecologists (ACOG) considers 200 mg caffeine daily safe during pregnancy, and no evidence suggests an increased risk of congenital malformations.<xref ref-type="bibr" rid="article-18756.r29">[29]</xref>&#x000a0;However, some studies have suggested that high caffeine consumption during pregnancy (more than 400 mg/d) may be associated with lower birth weights due to intrauterine growth restriction and an increased risk of miscarriage, although not preterm birth.<xref ref-type="bibr" rid="article-18756.r30">[30]</xref><xref ref-type="bibr" rid="article-18756.r31">[31]</xref>&#x000a0;Nonetheless, the evidence regarding lower birth weight and miscarriage is currently inconclusive and requires further investigation.<xref ref-type="bibr" rid="article-18756.r32">[32]</xref>&#x000a0;Caffeine is considered a pregnancy category C drug.<xref ref-type="bibr" rid="article-18756.r33">[33]</xref></p>
        <p><bold>Breastfeeding considerations:</bold>&#x000a0;Caffeine is detectable in breast milk. Infants of mothers with very high caffeine intake, roughly equivalent to consuming 10 or more cups of coffee daily, may experience jitteriness and disrupted sleep patterns. Notably, mothers are suggested to&#x000a0;limit their caffeine intake to 300 to 500 mg daily, although European guidelines recommend a likely safe level of 200 mg. Lower intake levels are advisable for mothers of preterm infants due to slower caffeine metabolism in these infants. Additionally, consuming more than 450 mL of coffee daily may decrease iron levels in breast milk, potentially leading to mild iron deficiency anemia in some breastfed infants.<xref ref-type="bibr" rid="article-18756.r34">[34]</xref></p>
        <p><bold>Pediatric patients:&#x000a0;</bold>Caffeine citrate injection is FDA-approved for treating apnea of prematurity. According to the manufacturing label, the recommended dosages for this condition are outlined in the table below.</p>
        <table-wrap id="article-18756.table0" position="float" orientation="portrait">
          <caption>
            <title>Table.&#x000a0;Caffeine Citrate Dosages for Apnea of&#x000a0;Prematurity</title>
          </caption>
          <table style="width: 800px;" border="1" cellspacing="1" cellpadding="2">
            <tbody>
              <tr style="height: 59px;">
                <td style="text-align: center; width: 128.113px; height: 59px;" rowspan="1" colspan="1">
<p><bold>Doses</bold></p>
</td>
                <td style="text-align: center; width: 142.887px; height: 59px;" rowspan="1" colspan="1">
<p><bold>Dose of caffeine citrate (mg/kg)</bold></p>
</td>
                <td style="text-align: center; width: 221px; height: 59px;" rowspan="1" colspan="1">
<p><bold>Route</bold></p>
<p><bold>(IV:&#x000a0;A syringe infusion pump)</bold></p>
</td>
                <td style="text-align: center; width: 330px; height: 59px;" rowspan="1" colspan="1">
<p><bold>Frequency</bold></p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="text-align: center; width: 128.113px; height: 35px;" rowspan="1" colspan="1">
<p><bold>Loading dose</bold></p>
</td>
                <td style="text-align: center; width: 142.887px; height: 35px;" rowspan="1" colspan="1">
<p>20</p>
</td>
                <td style="text-align: center; width: 221px; height: 35px;" rowspan="1" colspan="1">
<p>IV (over 30 minutes)</p>
</td>
                <td style="text-align: center; width: 330px; height: 35px;" rowspan="1" colspan="1">
<p>One time</p>
</td>
              </tr>
              <tr style="height: 50.6667px;">
                <td style="text-align: center; width: 128.113px; height: 50.6667px;" rowspan="1" colspan="1">
<p><bold>Maintenance dose</bold></p>
</td>
                <td style="text-align: center; width: 142.887px; height: 50.6667px;" rowspan="1" colspan="1">
<p>5</p>
</td>
                <td style="text-align: center; width: 221px; height: 50.6667px;" rowspan="1" colspan="1">
<p>IV&#x000a0;(over 10 minutes) or orally</p>
</td>
                <td style="text-align: center; width: 330px; height: 50.6667px;" rowspan="1" colspan="1">
<p>Every 24 hours (beginning 24 hours after the loading dose)</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p><bold>Older patients:</bold>&#x000a0;According to a cohort study, coffee and caffeine consumption exhibited a notable correlation with a reduced risk of dementia in a dose-dependent manner, especially among men.<xref ref-type="bibr" rid="article-18756.r35">[35]</xref></p>
      </sec>
      <sec id="article-18756.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>As with many drugs or medications, a wide array of adverse effects is associated with caffeine use. These effects vary from mild to severe and, in some cases, can be fatal, depending on the dose consumed and an individual's sensitivity to the drug. The most frequently reported adverse effects are outlined below. Mortality is usually associated with cardiac arrhythmia, hypotension, myocardial infarction, electrolyte disturbances, and aspiration.<xref ref-type="bibr" rid="article-18756.r11">[11]</xref><xref ref-type="bibr" rid="article-18756.r36">[36]</xref></p>
        <p>
<bold>Mild Adverse Effects</bold>
</p>
        <p>Mild adverse effects of caffeine include anxiety, restlessness, fidgeting, insomnia, facial flushing, increased urination, irritability, muscle twitches or tremors, agitation, tachycardia or irregular heart rate,&#x000a0;and gastrointestinal&#x000a0;irritation.</p>
        <p>
<bold>Severe Adverse Effects</bold>
</p>
        <p>Severe adverse effects may include disorientation, hallucinations, psychosis, seizures, arrhythmias, ischemia, and rhabdomyolysis. Additionally, caffeine can lead to withdrawal symptoms if habitual users abruptly cease consumption. These symptoms typically begin 12 to 24 hours after the last intake, peak in 1 to 2 days, and may endure for up to 1 week. However, withdrawal can be avoided by gradually tapering off caffeine rather than abruptly discontinuing it. In the event of symptoms, they can be promptly reversed by re-administering caffeine.<xref ref-type="bibr" rid="article-18756.r37">[37]</xref></p>
        <p>Lastly, when caffeine is used to treat apnea of prematurity, it is normal to observe evidence of an increased risk of necrotizing enterocolitis in neonates.<xref ref-type="bibr" rid="article-18756.r38">[38]</xref>&#x000a0;According to the 2023 guidelines from the American College of Cardiology (ACC), American Heart Association (AHA), American College of Clinical Pharmacy (ACCP), and Heart Rhythm Society (HRS), advising patients with atrial fibrillation to abstain from caffeine to prevent atrial fibrillation episodes lacks supporting evidence. However, caffeine avoidance may alleviate symptoms in patients who find that caffeine exacerbates their atrial fibrillation symptoms.</p>
        <p>Current research does not preclude the possibility of individual-specific idiosyncratic reactions between caffeine and atrial fibrillation. Additionally, caffeine may mimic symptoms such as palpitations or enhance awareness of heart rhythm irregularities.<xref ref-type="bibr" rid="article-18756.r39">[39]</xref>&#x000a0;A&#x000a0;systematic study supports sleep hygiene recommendations to avoid substantial caffeine intake at least 6 hours before bedtime due to its significant disruptive effects on sleep.<xref ref-type="bibr" rid="article-18756.r40">[40]</xref></p>
        <p>
<bold>Drug-Drug Interactions</bold>
</p>
        <p>The CYP1A2 enzyme metabolizes caffeine and functions as a competitive inhibitor of this enzyme. Consequently, caffeine can interact with various psychiatric medications, including antidepressants, antipsychotics, anxiolytics, and sedatives.<xref ref-type="bibr" rid="article-18756.r41">[41]</xref>&#x000a0;As CYP1A2 metabolizes tizanidine, concurrent use with caffeine should be avoided.<xref ref-type="bibr" rid="article-18756.r42">[42]</xref>&#x000a0;Additionally, bupropion can lower the seizure threshold, so caution should be exercised when using it concurrently with caffeine.<xref ref-type="bibr" rid="article-18756.r43">[43]</xref>&#x000a0;Furthermore, the sedative effects of alcohol and the psychoactive stimulant effects of caffeine can mask their respective influences on both sleep quantity and sleep quality.<xref ref-type="bibr" rid="article-18756.r44">[44]</xref></p>
      </sec>
      <sec id="article-18756.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Although no absolute contraindications to caffeine are recognized, caution is necessary in certain medical conditions, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Documented hypersensitivity</p>
          </list-item>
          <list-item>
            <p>Severe anxiety</p>
          </list-item>
          <list-item>
            <p>Cardiovascular disease or symptomatic cardiac arrhythmias</p>
          </list-item>
          <list-item>
            <p>Peptic ulcer disease or gastroesophageal reflux disease</p>
          </list-item>
          <list-item>
            <p>Hepatic impairment</p>
          </list-item>
          <list-item>
            <p>Renal impairment</p>
          </list-item>
          <list-item>
            <p>Seizures (as caffeine may lower seizure threshold)</p>
          </list-item>
          <list-item>
            <p>Pregnancy&#x000a0;<xref ref-type="bibr" rid="article-18756.r45">[45]</xref><xref ref-type="bibr" rid="article-18756.r46">[46]</xref><xref ref-type="bibr" rid="article-18756.r47">[47]</xref><xref ref-type="bibr" rid="article-18756.r48">[48]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18756.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>The average dose of caffeine for adults is 2.4 mg/kg/d; however, daily doses of up to 400 mg are considered safe.<xref ref-type="bibr" rid="article-18756.r49">[49]</xref>&#x000a0;A 100 mg dose of caffeine generally increases blood levels by 5 to 6 mg/L.<xref ref-type="bibr" rid="article-18756.r50">[50]</xref>&#x000a0;Severe intoxication, characterized by altered mentation, vomiting, and hypotension, has been reported at levels of 80 mg/L. The average blood level in patients who succumb to caffeine toxicity is 180 mg/L (&#x000b1;97 mg/L).<xref ref-type="bibr" rid="article-18756.r51">[51]</xref>&#x000a0;For the treatment of apnea of prematurity, caffeine is administered with therapeutic index goals of&#x000a0;5 to 25 mg/L.<xref ref-type="bibr" rid="article-18756.r52">[52]</xref><xref ref-type="bibr" rid="article-18756.r53">[53]</xref></p>
      </sec>
      <sec id="article-18756.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>
<bold>Signs and Symptoms of Overdose</bold>
</p>
        <p>Caffeine consumption is generally regarded as safe. Additive caffeine in most substances does not necessitate FDA approval as long as consumption remains within safe levels stipulated by the statute. A typical dose of caffeine is around 70 to 100 mg per drink. While there is no recommended daily allowance for caffeine, doses of up to 400 mg/d are deemed safe.<xref ref-type="bibr" rid="article-18756.r54">[54]</xref></p>
        <p>The exact LD50 for humans varies and largely depends on individual sensitivity to caffeine. However, the estimated LD50 is between 150&#x000a0;and 200 mg/kg. Case reports indicate that doses as low as 57 mg/kg have resulted in fatalities. A toxic dose of caffeine, where significant adverse effects such as tachycardia, arrhythmia, altered mentation, and seizures may occur, is estimated to be around 1.2 g. The estimates of a life-threatening dose of caffeine range from 10 to 14 g.</p>
        <p>
<bold>Management of Overdose</bold>
</p>
        <p>The treatment for mild ingestions primarily involves supportive care. However, in cases of more severe ingestions, additional interventions may be necessary. Patients may require intubation to protect the airway from vomiting or altered mental status. Benzodiazepines can be administered to abort any seizures that develop. If IV fluid resuscitation fails to address persistent hypotension, patients may need vasopressors. Phenylephrine or norepinephrine is typically the first-line vasopressor, with phenylephrine being preferable due to its &#x003b1;-agonism and reflex bradycardia.</p>
        <p>Magnesium and &#x003b2;-blockers can combat cardiac arrhythmias secondary to the hyperadrenergic response.<xref ref-type="bibr" rid="article-18756.r55">[55]</xref>&#x000a0;The ultra-short-acting &#x003b2;1-selective blocker esmolol has been used successfully in several case reports for this indication. In the case of lethal arrhythmias, patients will require defibrillation and resuscitation according to advanced cardiac life support protocols.<xref ref-type="bibr" rid="article-18756.r45">[45]</xref>&#x000a0;Additionally, activated charcoal, intralipid infusion, and hemodialysis can aid in preventing further metabolism and subsequent effects of caffeine overdose.<xref ref-type="bibr" rid="article-18756.r36">[36]</xref><xref ref-type="bibr" rid="article-18756.r56">[56]</xref></p>
      </sec>
      <sec id="article-18756.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Caffeine consumption is generally considered safe in moderate amounts. However, the prevalence of high-energy drinks containing excessive caffeine levels has escalated the problem of caffeine toxicity.<xref ref-type="bibr" rid="article-18756.r57">[57]</xref> These concentrated caffeinated beverages pose a significant risk on their own, but the danger escalates when combined with other illicit substances such as tobacco and alcohol. In recent years, numerous fatalities have been reported following the ingestion of such combinations.</p>
        <p>Addressing caffeine toxicity or adverse effects necessitates the collaboration of an interprofessional healthcare team to achieve optimal outcomes. In cases where caffeine is used for apnea of prematurity, consultation with a pediatrician and admission to a neonatal intensive care unit may be necessary.<xref ref-type="bibr" rid="article-18756.r1">[1]</xref>&#x000a0;When&#x000a0;using caffeine therapeutically, it is essential to inquire about other potential sources of caffeine to prevent toxicity. Healthcare team members are well-positioned to educate the public about the risks associated with high-energy drinks and related products. Clinicians, nursing staff, and pharmacists should be ready to offer counseling to patients who may be consuming excessive amounts of caffeine. While no absolute contraindications to caffeine exist, patients with cardiac disorders, panic disorder, anxiety, or elevated stress levels should be advised to avoid caffeine. An interprofessional healthcare team is well-equipped to educate patients appropriately in this regard.</p>
      </sec>
      <sec id="article-18756.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18756&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18756">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18756/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18756">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18756.s11">
        <title>References</title>
        <ref id="article-18756.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Long</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>XS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors.</article-title>
            <source>Front Pharmacol</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>681842</fpage>
            <pub-id pub-id-type="pmid">34381359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathew</surname>
                <given-names>OP</given-names>
              </name>
            </person-group>
            <article-title>Apnea of prematurity: pathogenesis and management strategies.</article-title>
            <source>J Perinatol</source>
            <year>2011</year>
            <month>May</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>302</fpage>
            <page-range>302-10</page-range>
            <pub-id pub-id-type="pmid">21127467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial.</article-title>
            <source>Biol Neonate</source>
            <year>2005</year>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>208</fpage>
            <page-range>208-13</page-range>
            <pub-id pub-id-type="pmid">16210843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klompas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Branson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cawcutt</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Crist</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eichenwald</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maragakis</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Priebe</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Speck</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yokoe</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Berenholtz</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>43</volume>
            <issue>6</issue>
            <fpage>687</fpage>
            <page-range>687-713</page-range>
            <pub-id pub-id-type="pmid">35589091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliphant</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Hanning</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>McKinlay</surname>
                <given-names>CJD</given-names>
              </name>
              <name>
                <surname>Alsweiler</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and meta-analysis.</article-title>
            <source>J Perinatol</source>
            <year>2024</year>
            <month>Jun</month>
            <volume>44</volume>
            <issue>6</issue>
            <fpage>785</fpage>
            <page-range>785-801</page-range>
            <pub-id pub-id-type="pmid">38553606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kugelman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Durand</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A comprehensive approach to the prevention of bronchopulmonary dysplasia.</article-title>
            <source>Pediatr Pulmonol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>46</volume>
            <issue>12</issue>
            <fpage>1153</fpage>
            <page-range>1153-65</page-range>
            <pub-id pub-id-type="pmid">21815280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nehlig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Daval</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Debry</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects.</article-title>
            <source>Brain Res Brain Res Rev</source>
            <year>1992</year>
            <season>May-Aug</season>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-70</page-range>
            <pub-id pub-id-type="pmid">1356551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pesta</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Angadi</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Burtscher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance.</article-title>
            <source>Nutr Metab (Lond)</source>
            <year>2013</year>
            <month>Dec</month>
            <day>13</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <pub-id pub-id-type="pmid">24330705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uppal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sondekoppam</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ansari</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Baber</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>DelPizzo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>D&#x000ee;rzu</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Kalagara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kissoon</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Kranz</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Leffert</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lobo</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Moka</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Sehmbi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vallejo</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Volk</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Narouze</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Consensus Practice Guidelines on Postdural Puncture Headache From a Multisociety, International Working Group: A Summary Report.</article-title>
            <source>JAMA Netw Open</source>
            <year>2023</year>
            <month>Aug</month>
            <day>01</day>
            <volume>6</volume>
            <issue>8</issue>
            <fpage>e2325387</fpage>
            <pub-id pub-id-type="pmid">37581893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freedman</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Abnet</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Hollenbeck</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Association of coffee drinking with total and cause-specific mortality.</article-title>
            <source>N Engl J Med</source>
            <year>2012</year>
            <month>May</month>
            <day>17</day>
            <volume>366</volume>
            <issue>20</issue>
            <fpage>1891</fpage>
            <page-range>1891-904</page-range>
            <pub-id pub-id-type="pmid">22591295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lara</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Caffeine, mental health, and psychiatric disorders.</article-title>
            <source>J Alzheimers Dis</source>
            <year>2010</year>
            <volume>20 Suppl 1</volume>
            <fpage>S239</fpage>
            <page-range>S239-48</page-range>
            <pub-id pub-id-type="pmid">20164571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunha</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Agostinho</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline.</article-title>
            <source>J Alzheimers Dis</source>
            <year>2010</year>
            <volume>20 Suppl 1</volume>
            <fpage>S95</fpage>
            <page-range>S95-116</page-range>
            <pub-id pub-id-type="pmid">20182043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arendash</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Schleif</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Rezai-Zadeh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Zacharia</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Cracchiolo</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Shippy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.</article-title>
            <source>Neuroscience</source>
            <year>2006</year>
            <month>Nov</month>
            <day>03</day>
            <volume>142</volume>
            <issue>4</issue>
            <fpage>941</fpage>
            <page-range>941-52</page-range>
            <pub-id pub-id-type="pmid">16938404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vaz-Carneiro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lunet</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Caffeine intake and dementia: systematic review and meta-analysis.</article-title>
            <source>J Alzheimers Dis</source>
            <year>2010</year>
            <volume>20 Suppl 1</volume>
            <fpage>S187</fpage>
            <page-range>S187-204</page-range>
            <pub-id pub-id-type="pmid">20182026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayans</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Walling</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acute Migraine Headache: Treatment Strategies.</article-title>
            <source>Am Fam Physician</source>
            <year>2018</year>
            <month>Feb</month>
            <day>15</day>
            <volume>97</volume>
            <issue>4</issue>
            <fpage>243</fpage>
            <page-range>243-251</page-range>
            <pub-id pub-id-type="pmid">29671521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lv</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Effects of Acute Ingestion of Caffeine Capsules on Muscle Strength and Muscle Endurance: A Systematic Review and Meta-Analysis.</article-title>
            <source>Nutrients</source>
            <year>2024</year>
            <month>Apr</month>
            <day>12</day>
            <volume>16</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">38674836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferr&#x000e9;</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>An update on the mechanisms of the psychostimulant effects of caffeine.</article-title>
            <source>J Neurochem</source>
            <year>2008</year>
            <month>May</month>
            <volume>105</volume>
            <issue>4</issue>
            <fpage>1067</fpage>
            <page-range>1067-79</page-range>
            <pub-id pub-id-type="pmid">18088379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Borgkvist</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Usiello</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Caffeine as a psychomotor stimulant: mechanism of action.</article-title>
            <source>Cell Mol Life Sci</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>61</volume>
            <issue>7-8</issue>
            <fpage>857</fpage>
            <page-range>857-72</page-range>
            <pub-id pub-id-type="pmid">15095008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Echeverri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Montes</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Cabrera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gal&#x000e1;n</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Prieto</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Caffeine's Vascular Mechanisms of Action.</article-title>
            <source>Int J Vasc Med</source>
            <year>2010</year>
            <volume>2010</volume>
            <fpage>834060</fpage>
            <pub-id pub-id-type="pmid">21188209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boekema</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Samsom</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Berge Henegouwen</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Smout</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Coffee and gastrointestinal function: facts and fiction. A review.</article-title>
            <source>Scand J Gastroenterol Suppl</source>
            <year>1999</year>
            <volume>230</volume>
            <fpage>35</fpage>
            <page-range>35-9</page-range>
            <pub-id pub-id-type="pmid">10499460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ikeda-Murakami</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ikeda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Central Nervous System Stimulants Limit Caffeine Transport at the Blood-Cerebrospinal Fluid Barrier.</article-title>
            <source>Int J Mol Sci</source>
            <year>2022</year>
            <month>Feb</month>
            <day>07</day>
            <volume>23</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">35163784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zandvliet</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Huitema</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>de Jonge</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>den Hoed</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sparidans</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Hendriks</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>van den Brink</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>van Ree</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Beijnen</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine.</article-title>
            <source>Basic Clin Pharmacol Toxicol</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-9</page-range>
            <pub-id pub-id-type="pmid">15667599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larsson</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Woolf</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Appraisal of the causal effect of plasma caffeine on adiposity, type 2 diabetes, and cardiovascular disease: two sample mendelian randomisation study.</article-title>
            <source>BMJ Med</source>
            <year>2023</year>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-8</page-range>
            <pub-id pub-id-type="pmid">36936261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fredholm</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>B&#x000e4;ttig</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Holm&#x000e9;n</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nehlig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zvartau</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.</article-title>
            <source>Pharmacol Rev</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <page-range>83-133</page-range>
            <pub-id pub-id-type="pmid">10049999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verbeeck</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.</article-title>
            <source>Eur J Clin Pharmacol</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>64</volume>
            <issue>12</issue>
            <fpage>1147</fpage>
            <page-range>1147-61</page-range>
            <pub-id pub-id-type="pmid">18762933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laizure</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Meibohm</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>ZY</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Comparison of caffeine disposition following administration by oral solution (energy drink) and inspired powder (AeroShot) in human subjects.</article-title>
            <source>Br J Clin Pharmacol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>83</volume>
            <issue>12</issue>
            <fpage>2687</fpage>
            <page-range>2687-2694</page-range>
            <pub-id pub-id-type="pmid">28758694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r27">
          <label>27</label>
          <element-citation publication-type="book">
            <chapter-title>Caffeine</chapter-title>
            <source>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]</source>
            <publisher-name>National Institute of Diabetes and Digestive and Kidney Diseases</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2020</year>
            <month>6</month>
            <day>18</day>
            <pub-id pub-id-type="pmid">32716623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aithal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kandasamy</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The Babyccino: The Role of Caffeine in the Prevention of Acute Kidney Injury in Neonates-A Literature Review.</article-title>
            <source>Healthcare (Basel)</source>
            <year>2024</year>
            <month>Feb</month>
            <day>23</day>
            <volume>12</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">38470639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Neelakantan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Dam</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis.</article-title>
            <source>BMC Med</source>
            <year>2014</year>
            <month>Sep</month>
            <day>19</day>
            <volume>12</volume>
            <fpage>174</fpage>
            <pub-id pub-id-type="pmid">25238871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Neelakantan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Dam</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Maternal caffeine intake during pregnancy and risk of pregnancy loss: a categorical and dose-response meta-analysis of prospective studies.</article-title>
            <source>Public Health Nutr</source>
            <year>2016</year>
            <month>May</month>
            <volume>19</volume>
            <issue>7</issue>
            <fpage>1233</fpage>
            <page-range>1233-44</page-range>
            <pub-id pub-id-type="pmid">26329421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bracken</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Triche</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Belanger</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hellenbrand</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Leaderer</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Association of maternal caffeine consumption with decrements in fetal growth.</article-title>
            <source>Am J Epidemiol</source>
            <year>2003</year>
            <month>Mar</month>
            <day>01</day>
            <volume>157</volume>
            <issue>5</issue>
            <fpage>456</fpage>
            <page-range>456-66</page-range>
            <pub-id pub-id-type="pmid">12615610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brent</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Christian</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Diener</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of the reproductive and developmental risks of caffeine.</article-title>
            <source>Birth Defects Res B Dev Reprod Toxicol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>152</fpage>
            <page-range>152-87</page-range>
            <pub-id pub-id-type="pmid">21370398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <article-title>ACOG CommitteeOpinion No. 462: Moderate caffeine consumption during pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>116</volume>
            <issue>2 Pt 1</issue>
            <fpage>467</fpage>
            <page-range>467-468</page-range>
            <pub-id pub-id-type="pmid">20664420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r34">
          <label>34</label>
          <element-citation publication-type="book">
            <chapter-title>Caffeine</chapter-title>
            <source>Drugs and Lactation Database (LactMed&#x000ae;) [Internet]</source>
            <publisher-name>National Institute of Child Health and Human Development</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2024</year>
            <month>1</month>
            <day>15</day>
            <pub-id pub-id-type="pmid">30000527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsushita</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nakanishi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kitamura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kabasawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Takachi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Oshiki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tsugane</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yamazaki</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Association of coffee, green tea, and caffeine with the risk of dementia in older Japanese people.</article-title>
            <source>J Am Geriatr Soc</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>69</volume>
            <issue>12</issue>
            <fpage>3529</fpage>
            <page-range>3529-3544</page-range>
            <pub-id pub-id-type="pmid">34624929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kerrigan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lindsey</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Fatal caffeine overdose: two case reports.</article-title>
            <source>Forensic Sci Int</source>
            <year>2005</year>
            <month>Oct</month>
            <day>04</day>
            <volume>153</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-9</page-range>
            <pub-id pub-id-type="pmid">15935584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Juliano</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features.</article-title>
            <source>Psychopharmacology (Berl)</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>176</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-29</page-range>
            <pub-id pub-id-type="pmid">15448977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cox</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hashem</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Tebbs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bookstaver</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Iskersky</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of caffeine and the development of necrotizing enterocolitis.</article-title>
            <source>J Neonatal Perinatal Med</source>
            <year>2015</year>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>339</fpage>
            <page-range>339-47</page-range>
            <pub-id pub-id-type="pmid">26757002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Writing Committee Members</collab>
              <name>
                <surname>Joglar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Armbruster</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Chyou</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Cronin</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Deswal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eckhardt</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Goldberger</surname>
                <given-names>ZD</given-names>
              </name>
              <name>
                <surname>Gopinathannair</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gorenek</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Hlatky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hogan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ibeh</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Indik</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kido</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kusumoto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Linta</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Patton</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Piccini</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Streur</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Times</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tisdale</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Van Wagoner</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint&#x000a0;Committee&#x000a0;on&#x000a0;Clinical Practice Guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2024</year>
            <month>Jan</month>
            <day>02</day>
            <volume>83</volume>
            <issue>1</issue>
            <fpage>109</fpage>
            <page-range>109-279</page-range>
            <pub-id pub-id-type="pmid">38043043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drake</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Roehrs</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shambroom</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed.</article-title>
            <source>J Clin Sleep Med</source>
            <year>2013</year>
            <month>Nov</month>
            <day>15</day>
            <volume>9</volume>
            <issue>11</issue>
            <fpage>1195</fpage>
            <page-range>1195-200</page-range>
            <pub-id pub-id-type="pmid">24235903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Broderick</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Dennis</surname>
                <given-names>LW</given-names>
              </name>
            </person-group>
            <article-title>Caffeine and psychiatric medication interactions: a review.</article-title>
            <source>J Okla State Med Assoc</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>98</volume>
            <issue>8</issue>
            <fpage>380</fpage>
            <page-range>380-4</page-range>
            <pub-id pub-id-type="pmid">16206866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Villa-Zapata</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Lumbreras</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Horn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Malone</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS).</article-title>
            <source>Drug Saf</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>45</volume>
            <issue>8</issue>
            <fpage>863</fpage>
            <page-range>863-871</page-range>
            <pub-id pub-id-type="pmid">35834155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marok</surname>
                <given-names>FZ</given-names>
              </name>
              <name>
                <surname>Fuhr</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Hanke</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Selzer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lehr</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network.</article-title>
            <source>Pharmaceutics</source>
            <year>2021</year>
            <month>Mar</month>
            <day>04</day>
            <volume>13</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">33806634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Sleep, alcohol, and caffeine in financial traders.</article-title>
            <source>PLoS One</source>
            <year>2023</year>
            <volume>18</volume>
            <issue>11</issue>
            <fpage>e0291675</fpage>
            <pub-id pub-id-type="pmid">37939019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fabrizio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Desiderio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Coyne</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Electrocardiogram Abnormalities of Caffeine Overdose.</article-title>
            <source>Circ Arrhythm Electrophysiol</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">27406599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tognetti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Murdaca</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fimiani</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Caffeine as a cause of urticaria-angioedema.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>5</volume>
            <issue>Suppl 2</issue>
            <fpage>S113</fpage>
            <page-range>S113-5</page-range>
            <pub-id pub-id-type="pmid">25593798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sugiyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tatewaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Onishi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yokoyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fujimatsu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hirata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fukushima</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Anaphylaxis due to caffeine.</article-title>
            <source>Asia Pac Allergy</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-6</page-range>
            <pub-id pub-id-type="pmid">25653922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>George</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Federico</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gom</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Teskey</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Caffeine exacerbates seizure-induced death via postictal hypoxia.</article-title>
            <source>Sci Rep</source>
            <year>2023</year>
            <month>Aug</month>
            <day>29</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>14150</fpage>
            <pub-id pub-id-type="pmid">37644198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poole</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>OJ</given-names>
              </name>
              <name>
                <surname>Roderick</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fallowfield</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Parkes</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes.</article-title>
            <source>BMJ</source>
            <year>2017</year>
            <month>Nov</month>
            <day>22</day>
            <volume>359</volume>
            <fpage>j5024</fpage>
            <pub-id pub-id-type="pmid">29167102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Review of Caffeine-Related Fatalities along with Postmortem Blood Concentrations in 51 Poisoning Deaths.</article-title>
            <source>J Anal Toxicol</source>
            <year>2017</year>
            <month>Apr</month>
            <day>01</day>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>167</fpage>
            <page-range>167-172</page-range>
            <pub-id pub-id-type="pmid">28334840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cappelletti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Piacentino</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fineschi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Frati</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cipolloni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Aromatario</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Caffeine-Related Deaths: Manner of Deaths and Categories at Risk.</article-title>
            <source>Nutrients</source>
            <year>2018</year>
            <month>May</month>
            <day>14</day>
            <volume>10</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">29757951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Francart</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Stegall-Zanation</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Apnea of prematurity: caffeine dose optimization.</article-title>
            <source>J Pediatr Pharmacol Ther</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-52</page-range>
            <pub-id pub-id-type="pmid">23616735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koch</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Datta</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Jost</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schulzke</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>van den Anker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pfister</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.</article-title>
            <source>J Pediatr</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>191</volume>
            <fpage>50</fpage>
            <page-range>50-56.e1</page-range>
            <pub-id pub-id-type="pmid">29173321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neves</surname>
                <given-names>DBDJ</given-names>
              </name>
              <name>
                <surname>Caldas</surname>
                <given-names>ED</given-names>
              </name>
            </person-group>
            <article-title>Determination of caffeine and identification of undeclared substances in dietary supplements and caffeine dietary exposure assessment.</article-title>
            <source>Food Chem Toxicol</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>105</volume>
            <fpage>194</fpage>
            <page-range>194-202</page-range>
            <pub-id pub-id-type="pmid">28366845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magdalan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zawadzki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Skowronek</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Czuba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Por&#x00119;bska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Soza&#x00144;ski</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Szpot</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Nonfatal and fatal intoxications with pure caffeine - report of three different cases.</article-title>
            <source>Forensic Sci Med Pathol</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>355</fpage>
            <page-range>355-358</page-range>
            <pub-id pub-id-type="pmid">28656354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muraro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Geraldini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bortot</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paoli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boscolo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intralipid in acute caffeine intoxication: a case report.</article-title>
            <source>J Anesth</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>895</fpage>
            <page-range>895-9</page-range>
            <pub-id pub-id-type="pmid">27272169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18756.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Costantino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maiese</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lazzari</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Casula</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Turillazzi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Frati</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fineschi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The Dark Side of Energy Drinks: A Comprehensive Review of Their Impact on the Human Body.</article-title>
            <source>Nutrients</source>
            <year>2023</year>
            <month>Sep</month>
            <day>09</day>
            <volume>15</volume>
            <issue>18</issue>
            <pub-id pub-id-type="pmid">37764707</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
